e-learning
resources
London 2016
Sunday, 04.09.2016
Asthma: mechanisms and biomarkers that promote clinical understanding
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obese patients with partially controlled asthma: Weight control shows more benefit in IgE low patients
Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Edin Jusufovic, Mitja Kosnik, Rifat Sejdinovic, Elida Turkusic, Munevera Osmic, Alma Nadarevic, Fransi Petrak, Dzenan Halilovic, Azra Jusufovic, Besim Prnjavorac
Source:
International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Session:
Asthma: mechanisms and biomarkers that promote clinical understanding
Session type:
Poster Discussion
Number:
574
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Edin Jusufovic, Mitja Kosnik, Rifat Sejdinovic, Elida Turkusic, Munevera Osmic, Alma Nadarevic, Fransi Petrak, Dzenan Halilovic, Azra Jusufovic, Besim Prnjavorac. Obese patients with partially controlled asthma: Weight control shows more benefit in IgE low patients. Eur Respir J 2016; 48: Suppl. 60, 574
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Asthma control in children: Comparison of different lung function parameters
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Lung clearance index in pediatric patients with asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Laser acupuncture effects on serum immunoglobulin E in A topic bronchial asthma patients
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016
Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Immunology indices in severe bronchial asthma with different levels of disease control in children
Source: Annual Congress 2013 –Asthma
Year: 2013
Lung clearance index in asthmatic patients
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Clinical phenotypes in asthmatic population with severe asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Study of the small airway and its role in pediatric asthma control assessment
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Variability of total serum IgE in moderate-to-severe asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept